Total Payments
$1.4M
2024 Payments
$179,286
Companies
37
Transactions
2,263
Medicare Patients
1,972
Medicare Billing
$150,698
Payment Breakdown by Category
Other$794,812 (56.3%)
Consulting$398,137 (28.2%)
Travel$155,317 (11.0%)
Food & Beverage$64,169 (4.5%)
Education$145.91 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $585,741 | 237 | 41.5% |
| Consulting Fee | $398,137 | 217 | 28.2% |
| Travel and Lodging | $155,317 | 797 | 11.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $99,363 | 45 | 7.0% |
| Honoraria | $95,576 | 48 | 6.8% |
| Food and Beverage | $64,169 | 910 | 4.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $11,583 | 7 | 0.8% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $2,550 | 1 | 0.2% |
| Education | $145.91 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $336,629 | 742 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $217,915 | 357 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $185,324 | 179 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $114,557 | 157 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $113,295 | 140 | $0 (2024) |
| ABBVIE INC. | $95,844 | 152 | $0 (2024) |
| Oyster Point Pharma, Inc. | $80,251 | 153 | $0 (2024) |
| Sight Sciences, Inc. | $71,742 | 68 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $47,364 | 66 | $0 (2024) |
| Reichert, Inc. | $25,886 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179,286 | 276 | Bausch & Lomb Americas Inc. ($66,985) |
| 2023 | $213,367 | 320 | Bausch & Lomb Americas Inc. ($41,488) |
| 2022 | $229,538 | 346 | Sun Pharmaceutical Industries Inc. ($66,711) |
| 2021 | $216,427 | 349 | Kala Pharmaceuticals, Inc. ($103,683) |
| 2020 | $96,639 | 172 | Sun Pharmaceutical Industries Inc. ($52,103) |
| 2019 | $130,159 | 245 | Allergan Inc. ($41,151) |
| 2018 | $154,816 | 199 | Johnson & Johnson Surgical Vision, Inc. ($89,149) |
| 2017 | $192,348 | 356 | Allergan Inc. ($108,323) |
All Payment Transactions
2,263 individual payment records from CMS Open Payments — Page 1 of 91
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Dry eyes | ||||||
| 12/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: Dry eyes | ||||||
| 12/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | Cash or cash equivalent | $39.32 | General |
| Category: Dry eyes | ||||||
| 12/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Dry eyes | ||||||
| 12/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $27.84 | General |
| Category: Dry eyes | ||||||
| 12/20/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: OPTOMETRY | ||||||
| 12/20/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/13/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $47.80 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $366.12 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $238.94 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $154.66 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $43.86 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $33.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | Cash or cash equivalent | $40.62 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Travel and Lodging | Cash or cash equivalent | $21.80 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | Cash or cash equivalent | $20.32 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Travel and Lodging | Cash or cash equivalent | $17.58 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), Xelpros, BromSite | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | In-kind items and services | $434.96 | General |
| Category: Dry eyes | ||||||
| 12/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | In-kind items and services | $300.95 | General |
| Category: Dry eyes | ||||||
| 12/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Dry eyes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 502 | 537 | $64,845 | $39,391 |
| 2022 | 4 | 461 | 492 | $60,610 | $38,242 |
| 2021 | 4 | 488 | 517 | $60,210 | $37,095 |
| 2020 | 4 | 521 | 554 | $59,490 | $35,970 |
Total Patients
1,972
Total Services
2,100
Medicare Billing
$150,698
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 317 | $41,210 | $25,961 | 63.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 171 | $16,245 | $10,558 | 65.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $4,160 | $2,410 | 57.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 16 | 17 | $3,230 | $461.89 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 305 | 309 | $40,170 | $27,089 | 67.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 130 | $12,350 | $8,130 | 65.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $4,290 | $2,585 | 60.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 19 | 20 | $3,800 | $437.66 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 288 | 289 | $35,210 | $23,965 | 68.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 124 | 152 | $13,020 | $9,006 | 69.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 41 | 41 | $5,330 | $3,203 | 60.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 35 | 35 | $6,650 | $922.43 | 13.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 313 | 316 | $34,760 | $22,779 | 65.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 121 | 150 | $11,250 | $8,279 | 73.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 54 | 54 | $7,020 | $3,943 | 56.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 33 | 34 | $6,460 | $969.48 | 15.0% |
About Dr. Marc Bloomenstein, OD
Dr. Marc Bloomenstein, OD is a Corneal and Contact Management healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568428910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Bloomenstein, OD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $179,286 received in 2024. These payments were reported across 2,263 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($585,741).
As a Medicare-enrolled provider, Bloomenstein has provided services to 1,972 Medicare beneficiaries, totaling 2,100 services with total Medicare billing of $150,698. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Corneal and Contact Management
- Other Specialties Optometrist
- Location Scottsdale, AZ
- Active Since 04/25/2006
- Last Updated 04/26/2022
- Taxonomy Code 152WC0802X
- Entity Type Individual
- NPI Number 1568428910
Products in Payments
- Tecnis 1-piece IOL (Device) $127,419
- Cequa (Drug) $126,494
- VUITY (Drug) $121,129
- EYSUVIS (Drug) $118,235
- CEQUA (Drug) $88,465
- RESTASIS (Drug) $87,772
- TYRVAYA (Drug) $80,251
- MIEBO (Drug) $74,672
- RESTASIS MULTIDOSE (Drug) $63,701
- XDEMVY (Drug) $46,864
- TEARCARE SYSTEM (Device) $45,389
- VYZULTA (Drug) $29,862
- STAR S4 IR Excimer Laser system (Device) $25,264
- OXERVATE (Drug) $23,519
- LUMIGAN (Drug) $22,677
- TearCare SmartLid (Device) $20,696
- LOTEMAX SM (Drug) $11,602
- XIIDRA (Drug) $9,048
- TearCare (Device) $5,629
- ILUX (Device) $5,410
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.